CYTOTECH ApS: Financial statements 2024
CVR: 19898504
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 165,957 and a net result of DKK -113,059 compared with DKK -81,311 the year before. That is a decrease of 9.1% compared with the year before. Equity in the 2024 report amounted to DKK 43,195. The solvency ratio was 33.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 165,957
- Profit/Loss
- DKK -113,059
- Equity
- DKK 43,195
- Total Assets
- DKK 129,390
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 166 t. | -113 t. | 43 t. | 1 |
| 2023 | - | 183 t. | -81 t. | 156 t. | 1 |
| 2022 | - | 273 t. | 51 t. | 238 t. | 1 |
| 2021 | - | 255 t. | -15 t. | 187 t. | 1 |
| 2020 | - | 266 t. | -11 t. | 201 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CYTOTECH ApS has published its annual report for 2023. Gross profit came to DKK 182,609, and the net result was DKK -81,311.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.